Study to Evaluate Multiple Doses of Fluconazole, a CYP3A4 and CYP2C9 Inhibitor, on the Pharmacokinetics of CTP-543 in Healthy Subjects
Clinical trial NCT05478772 · COMPLETED
Trial details
- NCT number
- NCT05478772
- Sponsor
- Concert Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-11
- Primary completion
- 2022-08-06
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.